NEW YORK — Rates of complications in vitrectomy for floaters were low in a real-world study presented at OSN New York Retina.Brian K. Do, MD, FASRS, said data from the IRIS Registry presented at the American Society of Retina Specialists annual meeting…
Preservative-free Lumigan gel noninferior to preserved solution
A preservative-free version of Lumigan gel led to IOP reductions comparable to a preserved version of the ophthalmic solution, with a lower rate of treatment-related ocular adverse events.The study, published in Journal of Glaucoma, demonstrated the no…
STAAR Surgical Announces Amendments to Alcon Merger Agreement
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the Company has agreed with Alcon I…
Q&A: Physicians’ stress levels mirror COVID-19 pandemic era
This year, physicians across the U.S. grappled with levels of stress and anxiety comparable to those experienced during the pandemic, according to a report from The Physician’s Foundation.Of the physicians who responded to the 2025 survey, 57% reported…
MCO-010 shows long-term safety in retinitis pigmentosa
MCO-010, an optogenetic therapy, demonstrated long-term safety and improved quality of life in patients with retinitis pigmentosa after a single intravitreal injection, according to a press release from Nanoscope Therapeutics.“Patients with RP suffer f…
VIDEO: Aflibercept 8 mg shows benefit in treatment-naive, prior-treated wet AMD patients
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Esther M. Bowie, MD, discusses real-world data from the IRIS Registry on aflibercept 8 mg in wet age-related macular degeneration.Bowie, professor in the department of ophthalm…